May 3rd - 5th, 2019
Omni Severin Hotel
40 W Jackson Place
Indianapolis, IN 46225
The educational process for Part III is both didactic and interactive with maximum audience participation. All of the most complex, interesting, and confusing cases experienced by Dr.Rouzier over the last ten years are presented. The participants decide on the corrective management with literature reviews to guide therapy. Be forewarned, as in the past, many concepts taught in other academies are contrary to the medical literature presented in this course. The attendee will decide therapy based on evidence based guidelines rather than public opinion. Although there are no medical boards for this type of practice, Part III is similar to a medical board that digs deeper into the complexities of age management medicine. Clinical cases will be analyzed to formulate appropriate treatments and management to improve the understanding and level of care provided to patients. In Parts I & II the cases and studies are simple and straightforward.
Part III: Mastering the Protocols for Optimization of Hormone Replacement Therapy - Complex Cases - May 2019
All participants will receive an electronic and printed syllabus with their registration. The eSyllabus will be available for download at least one week prior to the course. An email notification will be sent when it is available for download and will include links and instructions. This early release provides an opportunity to download and review the materials prior to the course.
PLEASE NOTE: We request you download the material prior to the event as internet access in the meeting room may be limited. We will also have flash drives available for those that find this easier than downloading. The syllabus can be saved in Adobe Reader which allows participants to add "sticky notes" directly on the slide as the speaker is talking. THese notes can be saved permanently to your document. Other recommended applications include iBooks (for apple mobile devices) and iAnnotate (for mobile devices). Lastly, put perhaps most important for many of us, a printed syllabus is available with an option for good old fashioned note taking.
Upon completion of this workshop the health care professional will be able to:
• Become proficient in newer age management protocols not presented in Parts I or II: more recent pertinent literature update and reviews, lab updates, and complex and interesting cases.
• Discuss the most current literature for bio-identical hormone replacement therapy (BHRT), thyroid, testosterone, DHEA, estrogen and progesterone.
• Determine the risks and benefits of transdermal estrogen vs. oral estrogen, why one vs. the other one, and review the statistics that claim HRT increases blood clots, or does it?
• Discuss new research demonstrating estrogen’s protective effects in men, the lack of any harm, and the harm of suppressing estrogen in men.
• Examine current policy statements for hormone replacement therapy by the North American Menopause Society (NAMS) and American College of Obstetricians and Gynecologists (ACOG), with a critique and review of their recommendations.
• Describe rational approaches for the use of progesterone in treating PMS and PPD.
• Discuss new therapies for prostate cancer as well as better diagnostic sensitivity and specificity of MRI-S scan.
• Determine current management strategies for preventing loss of pregnancy in Polycystic Ovary Syndrome (PCOS) as well as improving pregnancy rates with aromatase inhibitors.
• Describe the clinical evaluation including laboratory analysis and treatment of Vitamin D deficiency and how much is too much.
• Examine literature reviews as to what level of Vitamin D protects against cancer, CAD, osteoporosis, dementia, type II DM and AMD.
• Discuss the pathophysiology of vaginal atrophy and the use of rings, tabs, troches, creams, and DHEA. • Discuss the importance of sex hormone binding globulin (SHBG) in men and women and why it is most predictive of CAD, MS and cancer.
• Describe the data demonstrating that androgen suppression therapy, as well as estrogen deprivation, is associated with poor survival in men in comparison with placebo.
• Outline advanced treatment protocols for over 100 clinical cases based on clinical presentation, laboratory analysis, treatment, and complications in the Q & A sections.
• Discuss the inverse relationship of estrogen and prostate cancer. • Develop an understanding and treatment rationale for prostate cancer survivors through case presentations and literature review.
• Appreciate the lack of efficacy of estriol in spite of purported benefits.
• Describe the difference in clotting between Premarin®, Provera®, esterified estradiol, and micronized progesterone as per JAMA.
• Examine data proving that oral progesterone decreases clotting risk and inflammation as opposed to MPA that increases these risks as per the ESTHER trial.
• Appreciate the data demonstrating that only certain types of estrogen increase the production of fatty acid esters that result in protection against atherosclerosis and plaque deposition at the blood vessel wall.
• Demonstrate an understanding of the importance of maintaining low levels of aldosterone in patients with PCOS.
• Demonstrate an understanding of the importance of body weight in determining which type of HRT to prescribe. • Critique the data demonstrating that testosterone can both increase and decrease CVD in women and learn to decipher the correct approach.
• Identify the two mechanisms by which estrogen treats and protects against prostate cancer.
• Review treatment of endometrial proliferation with serial ultrasound results and laboratory monitoring.
• Illustrate a historical perspective on progesterone presenting no risk of breast cancer or VTE.
• Present over 200 complex case studies to compare, contrast and analyze treatment protocols.
• Demonstrate skills in case studies with interactive discussion to ensure interpretation and treatment protocols are as demonstrated in our evidenced based scientific literature.
• Examine the medical literature to understand how hormones affect cardiovascular disease for both men and women.
Dr. Neal Rouzier is a pioneer in the bio identical hormone replacement field, practicing almost since its inception in the early 1990’s. He has dedicated his life’s work to uncovering the medical literature that supports safe and effective protocols for unique and personalized patient care. He is the Director of the Preventive Medicine Clinics of the Desert, specializing in the medical management of aging and preventive care for men and women. He has treated more than 2,000 patients with natural hormone replacement therapy and is recognized as a renowned leader and expert in the field. Additionally, Dr. Rouzier is the author of Natural Hormone Replacement for Men and Women: How to Achieve Healthy Aging. He has over 16 years of experience as an educator and practicing physician, and 29 years of Emergency Medicine experience at Queen of the Valley Hospital in West Covina, CA.
back to top
Phone (317) 634-6664 (Group is under Worldlink Medical)
Room Block Rate $169.00 Room Block Rate expires April 19th, 2019.
Click Here to make your hotel room reservation
Nearest Airport is Indianapolis International (IND)
Initial Enrollment - $1,295.00
Discounted Price - $1,195.00
*If Registered By Friday, April 5th, 2019
Part III Graduate - $675.00
Staff Member (MA, RN, Office Mgr) - $675.00
If cancellation is received more than 3 weeks in advance a full credit can be applied to your account for future use. If less than 3 weeks a $350.00 cancellation fee applies and the balance will be applied as a credit to a future event.
AMA PRA Category 1 Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Foundation for Care Management (FCM) and Worldlink Medical. The Foundation for Care Management is accredited by the ACCME to provide continuing medical education for physicians.
FCM designates this educational activity for a maximum of 20 AMA PRA Category 1 CreditsTM.
Physicians should only claim credit commensurate with the extent of their participation in this activity.
The ACCME defines a “Commercial Interest” as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
The Foundation for Care Management is an approved provider of continuing nursing education by the Western Multi-State Division (WMSD), Approver of Continuing Nursing Education an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. 20 Nursing contact hour(s).
The Foundation for Care Management is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Program # 0347-9999-18-003-L01-P Objectives appropriate for pharmacists. This activity is 20 Contact Hours Pharmacy Credit. *This CME is Knowledge Based (K). Initial release May 4, 2018back to top
Phone (317) 634-6664 (Group is under Worldlink Medical)